Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Overview • DTC genetic testing PART 05: Market landscape • Overview • Market size and forecast • Five forces analysis PART 06: Segmentation by service • Diagnostic screening • Prenatal, newborn screening, and pre-implantation diagnosis • Relationship testing PART 07: Segmentation by channel • Overview • Direct sales • Clinical laboratories • Retail sales PART 08: Segmentation by geography • Americas • EMEA • APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Paradigm shift in business models • Next-generation sequencing and biochip for present and future genetic diagnosis • Development of online applications to serve customer needs PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • 23andMe • LabCorp • Myriad Genetics • Quest Diagnostics • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits  Exhibit 01: DTC genetic testing process Exhibit 02: Limitations of DTC genetic testing and key focus of companies Exhibit 03: Global DTC genetic testing market 2016-2021 ($ million) Exhibit 04: Adoption of DTC genetic testing and average cost of preferred tests Exhibit 05: Five forces analysis Exhibit 06: DTC genetic testing services: Adoption Exhibit 07: Global DTC genetic testing market: Segmentation by service 2016 Exhibit 08: Diagnostic screening using DTC genetic testing: Purpose, companies that offer services, and price Exhibit 09: Diagnostic screening using DTC genetic testing: Overview Exhibit 10: Diagnostic screening using DTC genetic testing: Market insights Exhibit 11: Prenatal, newborn screening, and pre-implantation diagnosis using DTC genetic testing services: Overview Exhibit 12: Prenatal, newborn screening, and pre-implantation diagnosis: Market insights Exhibit 13: Relationship testing using DTC genetic testing services: Overview Exhibit 14: Global DTC genetic testing market: Segmentation by distribution channel 2016 (% share) Exhibit 15: DTC genetic testing through direct sales: Overview Exhibit 16: Direct sales: Market impact analysis Exhibit 17: DTC genetic testing companies and laboratories: Consumer approach Exhibit 18: Clinical laboratories: Regulatory paradigm analysis Exhibit 19: Retail sales of paternity tests: Overview Exhibit 20: Global DTC genetic testing market: Segmentation by geography 2016 and 2021 ($ million) Exhibit 21: DTC genetic testing market in Americas: Overview Exhibit 22: DTC genetic testing market in Americas 2016-2021 ($ million) Exhibit 23: DTC genetic testing market based on countries in Americas: Analysis Exhibit 24: DTC genetic testing in US: Overview Exhibit 25: Role of regulatory in genetic tests and services in US Exhibit 26: DTC genetic testing in US: Market dynamics Exhibit 27: Legislations related to DTC genetic testing in European countries Exhibit 28: Hospital admissions for diabetes in EMEA 2008 and 2013 (per 10,000 people) Exhibit 29: DTC genetic testing in EMEA: Overview Exhibit 30: DTC genetic testing market in EMEA 2016-2021 ($ million) Exhibit 31: DTC genetic testing market based on countries in EMEA: Analysis Exhibit 32: DTC genetic testing in UK: Overview Exhibit 33: DTC genetic testing in UK: Market dynamics Exhibit 34: DTC genetic testing in APAC: Overview Exhibit 35: DTC genetic testing market in APAC 2016-2021 ($ million) Exhibit 36: DTC genetic testing market based on countries in EMEA: Analysis Exhibit 37: Growth of aging population aged 55 or more 2010-2050 (%) Exhibit 38: Sick leaves among people aged between 50 and 59 years in European countries due to chronic diseases 2013 (days) Exhibit 39: Clinical studies on DTC genetic testing awareness and market impact analysis Exhibit 40: Partnership models Exhibit 41: Price difference in hereditary breast cancer testing Exhibit 42: FDA warning letters to companies Exhibit 43: Business models of DTC genetic testing companies Exhibit 44: Applications and insights Exhibit 45: Competitive structure analysis of global DTC genetic testing market 2016 Exhibit 46: Competitive landscape analysis of global DTC genetic testing market 2016 Exhibit 47: Strategic recommendations for new entrants Exhibit 48: Key recommendations for companies in the global DTC genetic testing market Exhibit 49:andMe: Key highlights Exhibit 50:andMe: Strength assessment Exhibit 51:andMe: Strategy assessment Exhibit 52:andMe: Opportunity assessment Exhibit 53: LabCorp: Key highlights Exhibit 54: LabCorp: Strength assessment Exhibit 55: LabCorp: Strategy assessment Exhibit 56: LabCorp: Opportunity assessment Exhibit 57: Myriad Genetics: Key highlights Exhibit 58: Myriad Genetics: Strength assessment Exhibit 59: Myriad Genetics: Strategy assessment Exhibit 60: Myriad Genetics: Opportunity assessment Exhibit 61: Quest Diagnostics: Key highlights Exhibit 62: Quest Diagnostics: Strength assessment Exhibit 63: Quest Diagnostics: Strategy assessment Exhibit 64: Quest Diagnostics: Opportunity assessment Exhibit 65: Other prominent vendors

23andMe, LabCorp, Myriad Genetics, Quest Diagnostics, African Ancestry, Alpha Biolaboratories, Ambry Genetics, AncestrybyDNA, Anglia DNA Services, Canadian DNA Services, Centrillion Technology, Color Genomics, Counsyl, Dante Labs, DNA Diagnostics Center, DNA Family Check, DNA4Life, DNA Services of America, EasyDNA, Full Genomes, 24genetics, Gene By Gene, GHC GENETICS, Genetic Health, IDENTIGENE, IntelliGenetics, Invitae, Living DNA, Mapmygenome, MyHeritage, Pathway Genomics, Positive Bioscience, SureGenomics, Shuwen Health Sciences, Sonora Quest Laboratories, Test Me DNA, VCGS, Walk-In Lab, and Xcode.